These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9057358)

  • 1. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest?
    Kropshofer H; Hämmerling GJ; Vogt AB
    Immunol Today; 1997 Feb; 18(2):77-82. PubMed ID: 9057358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.
    Vogt AB; Kropshofer H; Hämmerling GJ
    Hum Immunol; 1997 May; 54(2):170-9. PubMed ID: 9297535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
    Kropshofer H; Hämmerling GJ; Vogt AB
    Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
    Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
    EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.
    van Ham SM; Grüneberg U; Malcherek G; Bröker I; Melms A; Trowsdale J
    J Exp Med; 1996 Nov; 184(5):2019-24. PubMed ID: 8920889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What to do with HLA-DO?
    van Ham M; van Lith M; Griekspoor A; Neefjes J
    Immunogenetics; 2000 Aug; 51(10):765-70. PubMed ID: 10970090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
    van Ham SM; Tjin EP; Lillemeier BF; Grüneberg U; van Meijgaarden KE; Pastoors L; Verwoerd D; Tulp A; Canas B; Rahman D; Ottenhoff TH; Pappin DJ; Trowsdale J; Neefjes J
    Curr Biol; 1997 Dec; 7(12):950-7. PubMed ID: 9382849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: editing of recycling class II:peptide complexes by HLA-DM.
    Pathak SS; Lich JD; Blum JS
    J Immunol; 2001 Jul; 167(2):632-5. PubMed ID: 11441064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
    Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
    Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational heterogeneity of MHC class II induced upon binding to different peptides is a key regulator in antigen presentation and epitope selection.
    Sadegh-Nasseri S; Natarajan S; Chou CL; Hartman IZ; Narayan K; Kim A
    Immunol Res; 2010 Jul; 47(1-3):56-64. PubMed ID: 20066513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.
    Mosyak L; Zaller DM; Wiley DC
    Immunity; 1998 Sep; 9(3):377-83. PubMed ID: 9768757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
    Schulze MS; Wucherpfennig KW
    Curr Opin Immunol; 2012 Feb; 24(1):105-11. PubMed ID: 22138314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide exchange in MHC molecules.
    Jensen PE; Weber DA; Thayer WP; Westerman LE; Dao CT
    Immunol Rev; 1999 Dec; 172():229-38. PubMed ID: 10631949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.
    Afridi S; Hoessli DC; Hameed MW
    Immunol Rev; 2016 Jul; 272(1):151-68. PubMed ID: 27319349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-DM, HLA-DO and tapasin: functional similarities and differences.
    Brocke P; Garbi N; Momburg F; Hämmerling GJ
    Curr Opin Immunol; 2002 Feb; 14(1):22-9. PubMed ID: 11790529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide.
    Sherman MA; Weber DA; Jensen PE
    Immunity; 1995 Aug; 3(2):197-205. PubMed ID: 7648393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.
    Mellins ED; Stern LJ
    Curr Opin Immunol; 2014 Feb; 26():115-22. PubMed ID: 24463216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Class II antigen processing compartments and the function of HLA-DM.
    Green JM; Pierce SK
    Int Rev Immunol; 1996; 13(3):209-19. PubMed ID: 8782742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.